s-adenosylmethionine has been researched along with Encephalopathy, Hepatic in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Acott, PD; Al-Khalidi, M; Crocker, JF; Dooley, K; Geldenhuys, L; Lee, SH; Murphy, MG; O'Regan, P | 1 |
| Keeffe, EB; Shores, NJ | 1 |
| Czarnecka, AM; Hilgier, W; Zielińska, M | 1 |
| Czarnecka, A; Jaźwiec, R; Milewski, K; Zielińska, M | 1 |
| Bozzi, A; Cangiano, C; Capocaccia, L; Cardelli-Cangiano, P; Gentile, S; Riggio, O; Rossi Fanelli, F; Strom, R | 1 |
| Carbone, G; Cerotto, GM; Corbosiero, L; De Caprio, M; Vitale, A | 1 |
| Grechko, VE; Liubshina, OV; Maev, IV; Vertkin, AL | 1 |
| Fischer, JE; James, JH | 1 |
1 review(s) available for s-adenosylmethionine and Encephalopathy, Hepatic
| Article | Year |
|---|---|
Is oral L-acyl-carnitine an effective therapy for hepatic encephalopathy? Review of the literature.
Topics: Administration, Oral; Carnitine; Hepatic Encephalopathy; Humans; Randomized Controlled Trials as Topic; Treatment Outcome | 2008 |
1 trial(s) available for s-adenosylmethionine and Encephalopathy, Hepatic
| Article | Year |
|---|---|
[Effectiveness of various hepatoprotective agents in liver encephalopathy].
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anticholesteremic Agents; Chronic Disease; Female; Hepatic Encephalopathy; Humans; Male; Middle Aged; S-Adenosylmethionine; Severity of Illness Index | 1999 |
6 other study(ies) available for s-adenosylmethionine and Encephalopathy, Hepatic
| Article | Year |
|---|---|
Carnitine, acylcarnitine and amino acid profiles analyzed by tandem mass spectrometry in a surfactant/virus mouse model of acute hepatic encephalopathy.
Topics: Amino Acids; Animals; Carnitine; Disease Models, Animal; Hepatic Encephalopathy; Influenza B virus; Mice; Surface-Active Agents; Tandem Mass Spectrometry; Time Factors | 2007 |
S-Adenosylmethionine Deficiency and Brain Accumulation of S-Adenosylhomocysteine in Thioacetamide-Induced Acute Liver Failure.
Topics: Animals; Brain; Cystathionine beta-Synthase; Glutathione; Hepatic Encephalopathy; Liver; Liver Failure, Acute; Male; Methionine Adenosyltransferase; Oxidative Stress; Rats; Rats, Sprague-Dawley; S-Adenosylhomocysteine; S-Adenosylmethionine; Thioacetamide | 2020 |
Intracerebral Administration of S-Adenosylhomocysteine or S-Adenosylmethionine Attenuates the Increases in the Cortical Extracellular Levels of Dimethylarginines Without Affecting cGMP Level in Rats with Acute Liver Failure.
Topics: Animals; Arginine; Cyclic GMP; Disease Models, Animal; Extracellular Space; Hepatic Encephalopathy; Liver Failure, Acute; Male; Prefrontal Cortex; Protein-Arginine N-Methyltransferases; Rats, Sprague-Dawley; RNA, Messenger; S-Adenosylhomocysteine; S-Adenosylmethionine; Signal Transduction | 2017 |
Simultaneous radioenzymatic determination of phenylethylamine, phenylethanolamine, tyramine and octopamine in plasma of patients with hepatic encephalopathy.
Topics: Ethanolamines; Hepatic Encephalopathy; Humans; Neurotransmitter Agents; Octopamine; Phenethylamines; S-Adenosylmethionine; Tyramine | 1981 |
[Behaviour of ammonemia during treatment of chronic/hyperammonemic hepatopathy with S-adenosyl-L-methionine].
Topics: Adult; Aged; Ammonia; Chronic Disease; Female; Hepatic Encephalopathy; Humans; Liver Diseases; Male; Middle Aged; S-Adenosylmethionine | 1980 |
Treatment of hepatic coma and hepatorenal syndrome. Mechanism of action of L-dopa and aramine.
Topics: Adult; Brain Chemistry; Carbon Isotopes; Cardiac Output; Dihydroxyphenylalanine; Female; Hepatic Encephalopathy; Humans; Kidney Diseases; Liver Diseases; Male; Metaraminol; Middle Aged; Natriuresis; Neurotransmitter Agents; Octopamine; Phenethylamines; S-Adenosylmethionine; Sympathetic Nervous System; Synapses | 1972 |